Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001209191-22-031170

SVP Marketing and Corp. Dev. gave up 411 shares (to pay taxes)

  • SVP Marketing and Corp. Dev. acquired 1,053 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Poirson Allen SVP Marketing and Corp. Dev. 2022-05-18 Option exercise +1,053 41,436 D
Poirson Allen SVP Marketing and Corp. Dev. 2022-05-18 Shares withheld for taxes −411 $9.65 $3,966 41,025 D
Derivatives
Poirson Allen SVP Marketing and Corp. Dev. 2022-05-18 Option exercise · Restricted Stock Units −1,053 11,593 D
Loading xslF345X03/doc4.xml…